Ignite Creation Date:
2025-12-26 @ 1:16 PM
Ignite Modification Date:
2025-12-31 @ 5:32 PM
Study NCT ID:
NCT02058706
Status:
COMPLETED
Last Update Posted:
2023-05-10
First Post:
2014-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer
Sponsor:
Barbara Ann Karmanos Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2021-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-02-06
First Submit QC Date:
None
Study First Post Date:
2014-02-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-08-23
Results First Submit QC Date:
None
Results First Post Date:
2023-05-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-09
Last Update Post Date:
2023-05-10
Last Update Post Date Type:
ACTUAL